IGHE and Alzheimer disease: Prakoeswa et al. randomized 22 patients <14 years of age with mild-to-moderate AD and elevated levels of total serum immunoglobulin E (IgE) to receive 12 weeks of either L. plantarum IS-10506 or placebo.